IL10 and neoplasm: Beyond the immunosuppressive activity ascribed to IL-10, Mumm and colleagues demonstrated its ability to induce mechanisms involved in anti-tumor immune surveillance, in particular by favoring the expression of IFN-γ by Th1 cells and activating anti-tumor CD8+ T cells (64).